Search research articles
Contact Us
Filters
Showing results (241-250 of 572) with videos related to
Page
of 58
Sort By:
JAMA Oncology
|
October 1, 2020
Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer: A Nonrandomized Phase 1 Clinical Trial
Ana Oaknin, Anna V Tinker, Lucy Gilbert, et al.
Journal of Tissue Viability
|
April 17, 2025
Evaluating alternating pressure air mattress effectiveness through the measurement of skin redness and blood perfusion
Sukhveer Singh Sandhu, Dawn L Denny, Rhoda A Owens, et al.
Scientific Reports
|
September 21, 2019
Statin use and the risk of colorectal cancer in a population-based electronic health records study
Gemma Ibáñez-Sanz, Elisabet Guinó, Caridad Pontes, et al.
Frontiers in Oncology
|
October 22, 2016
Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain
Valentina Rosato, Alessandra Tavani, Esther Gracia-Lavedan, et al.
Future Oncology (London, England)
|
August 24, 2021
Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer
Ana Oaknin, Anna V Tinker, Lucy Gilbert, et al.
Investigational New Drugs
|
March 20, 2020
A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFR
James M Cleary, Emiliano Calvo, Victor Moreno, et al.
JCO Oncology Practice
|
July 25, 2025
Derivation and External Validation of Objective Performance Status Among Patients With Metastatic Cancer
Eva Ruiz, Christopher R Manz, Anthony Girard, et al.
Molecular Cancer
|
March 7, 2014
Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer
Rebeca Sanz-Pamplona, Antoni Berenguer, David Cordero, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 10, 2024
Lurbinectedin in patients with small cell lung cancer with chemotherapy-free interval ≥30 days and without central nervous metastases
Solange Peters, José Trigo, Benjamin Besse, et al.
Human Molecular Genetics
|
January 22, 2021
Multi-omics analysis to identify susceptibility genes for colorectal cancer
Yuan Yuan, Jiandong Bao, Zhishan Chen, et al.
Page
of 58
Search research articles
Search
Showing results (241-250 of 572) with videos related to
Sort By:
Page
of 58
JAMA Oncology
|
October 1, 2020
Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer: A Nonrandomized Phase 1 Clinical Trial
Ana Oaknin, Anna V Tinker, Lucy Gilbert, et al.
Journal of Tissue Viability
|
April 17, 2025
Evaluating alternating pressure air mattress effectiveness through the measurement of skin redness and blood perfusion
Sukhveer Singh Sandhu, Dawn L Denny, Rhoda A Owens, et al.
Scientific Reports
|
September 21, 2019
Statin use and the risk of colorectal cancer in a population-based electronic health records study
Gemma Ibáñez-Sanz, Elisabet Guinó, Caridad Pontes, et al.
Frontiers in Oncology
|
October 22, 2016
Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain
Valentina Rosato, Alessandra Tavani, Esther Gracia-Lavedan, et al.
Future Oncology (London, England)
|
August 24, 2021
Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer
Ana Oaknin, Anna V Tinker, Lucy Gilbert, et al.
Investigational New Drugs
|
March 20, 2020
A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFR
James M Cleary, Emiliano Calvo, Victor Moreno, et al.
JCO Oncology Practice
|
July 25, 2025
Derivation and External Validation of Objective Performance Status Among Patients With Metastatic Cancer
Eva Ruiz, Christopher R Manz, Anthony Girard, et al.
Molecular Cancer
|
March 7, 2014
Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer
Rebeca Sanz-Pamplona, Antoni Berenguer, David Cordero, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 10, 2024
Lurbinectedin in patients with small cell lung cancer with chemotherapy-free interval ≥30 days and without central nervous metastases
Solange Peters, José Trigo, Benjamin Besse, et al.
Human Molecular Genetics
|
January 22, 2021
Multi-omics analysis to identify susceptibility genes for colorectal cancer
Yuan Yuan, Jiandong Bao, Zhishan Chen, et al.
Page
of 58